Filing Flows › Comparisons › ADIA vs NPHC
Adia Med vs Nutra Pharma: ADIA and NPHC compared
Adia Med is the larger company: $485K of revenue in its latest quarter (Q2 2026) against $34K for Nutra Pharma (Q2 2026). Adia Med is growing faster (+311% against -59% a year earlier).
Where the money goes: ADIA and NPHC
Adia Med (ADIA) · Q2 2026
Adia Med, Q2 2026: revenue $485K (+311% year over year), operating margin 10.7%, net earnings $40K, operating cash flow −$109K. The chart follows the revenue to costs, profit and cash.
Nutra Pharma (NPHC) · Q2 2026
Nutra Pharma, Q2 2026: revenue $34K (-59% year over year), net loss $3.9M, operating cash flow −$251K. The chart follows the revenue to costs, profit and cash.
| Adia Med (ADIA) | Nutra Pharma (NPHC) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $485K | $34K |
| Revenue growth, Y/Y | +311% | -59% |
| Gross margin | 58.2% | — |
| Operating margin | 10.7% | n/m |
| Net earnings | $40K | −$3.9M |
| Net margin | 8.3% | — |
| Operating cash flow | −$109K | −$251K |
Where the revenue comes from
Adia Med
- Medical Procedures: $330K (68%)
- Sales of Biologics: $152K (31%)
- Shipping and Delivery: $4K (1%)
Questions
Which is bigger, Adia Med or Nutra Pharma?
Adia Med is the larger company: $485K of revenue in its latest quarter (Q2 2026) against $34K for Nutra Pharma (Q2 2026).
Is Adia Med or Nutra Pharma growing faster?
Adia Med is growing faster (+311% against -59% a year earlier).
More: Adia Med earnings · how Adia Med makes money · Nutra Pharma earnings · how Nutra Pharma makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 19, 2026). Fiscal quarters can end on different dates. Not investment advice.